Lundbeck
HLUN-B.CO
#2707
Rank
C$9.07 B
Marketcap
C$9.14
Share price
-0.19%
Change (1 day)
-6.13%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): C$1.05

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$1.05. In 2025 the company made an earnings per share (EPS) of C$0.71 an increase over its 2024 EPS that were of C$0.62.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.0547.8%
2025C$0.7114.5%
2024C$0.6229.29%
2023C$0.4823.09%
2022C$0.3937.26%
2021C$0.28-84.61%
2020C$1.84-24.61%
2019C$2.44-42.06%
2018C$4.2140.7%
2017C$2.99146.26%
2016C$1.22-120.48%
2015C-$5.943231.32%
2014C-$0.18-115.78%
2013C$1.13-23.36%
2012C$1.47-48.01%
2011C$2.83-9.68%
2010C$3.1413.72%
2009C$2.7624.32%
2008C$2.22-6.05%
2007C$2.3681.77%
2006C$1.30-16.76%
2005C$1.56-17.58%
2004C$1.89